Mian et al. studied the role of SF3B1 mutation in a cohort of patients with MDS with ring sideroblasts and concluded that such alteration might have an initial role in the pathogenesis of that MDS subtype [31]. This evidence concerns the gene SF3B1 and myelodysplastic syndrome.